Tm Bioscience to Supply Jacobi Medical Center with TAG-IT™ Reagents
News Jan 23, 2006
"Using Tm’s platform approach, we have been able to greatly enhance our genetic screening abilities to the benefit of the large communities we serve," said Dr. Susan Gross, Co-Director of the Division of Reproductive Genetics at Jacobi Medical Center.
"The Tag-It™ technology has allowed us to create assays that generate accurate results rapidly while minimizing operator time."
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.